RNU7-56P

Across TCGA pan-cancer cohorts, RNU7-56P RNA is linked to patient survival in 11 of 34 cancer types, making it the most broadly survival-associated RNU7-56P data layer.

The strongest signal is observed in liver hepatocellular carcinoma (LIHC), where higher RNU7-56P RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated RNU7-56P expression acts as an unfavorable survival marker.

LIHC, SKCM, and THYM are the cancer types where RNU7-56P RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
LIHC	DFS	Tertile	III,IV	0.040	0.365	<.001	114	view →
SKCM	OS	Tertile	III,IV	0.190	0.708	<.001	81	view →
THYM	OS	Tertile	All	0.549	0.974	.001	54	view →
HNSC	OS	Tertile	II,III,IV	0.059	0.712	<.001	54	view →
OV	OS	Tertile	III,IV	0.201	0.330	.003	36	view →
BLCA	OS	Tertile	IV	0.111	0.590	<.001	18	view →
KIRP	DFS	Tertile	III,IV	0.191	0.720	.003	18	view →
CESC	OS	Tertile	II,III,IV	0.230	0.575	.025	12	view →
THCA	DFS	Tertile	IV	0.243	0.801	.021	9	view →
LUSC	OS	Tertile	II,III,IV	0.176	0.677	.047	9	view →
LGG	OS	Tertile	All	0.664	0.841	.015	6	view →

Pink = unfavorable, green = favorable. Showing the 11 strongest of 11 lineages.

RNU7-56P–LIHC (DFS)

Open the LIHC breakdown →